Kathryn Guarini

Director, Regeneron Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$0.7M

Companies

Latest trade

Sep 2, 2026

Companies

Regeneron PharmaceuticalsDirector −$0.7M

Trades

REGN Sold 400 shares at $850.00 · planned $0.3M Sep 2

REGN Sold 400 shares at $800.00 · planned $0.3M Aug 10

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.